We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$30.4B
AUM Growth
-$2.47B
Cap. Flow
-$610M
Cap. Flow %
-2%
Top 10 Hldgs %
27.14%
Holding
1,158
New
88
Increased
431
Reduced
443
Closed
102

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$114M
2
META icon
Meta Platforms (Facebook)
META
+$82M
3
TT icon
Trane Technologies
TT
+$81.5M
4
ARM icon
Arm
ARM
+$57.6M
5
MCD icon
McDonald's
MCD
+$47.8M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$91.3M
2
V icon
Visa
V
+$80.7M
3
GE icon
GE Aerospace
GE
+$73.5M
4
MSFT icon
Microsoft
MSFT
+$70M
5
TMO icon
Thermo Fisher Scientific
TMO
+$69.3M

Sector Composition

Rank Sector Weight
1 Technology 34.52%
2 Healthcare 14.6%
3 Consumer Discretionary 12.08%
4 Financials 10.25%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPRX icon
776
Royalty Pharma
RPRX
$26B
$1.27M ﹤0.01%
40,943
-115,188
-74% -$3.65M
CTO
777
CTO Realty Growth
CTO
$777M
$1.23M ﹤0.01%
63,877
+9,204
+17% +$179K
AOS icon
778
A.O. Smith
AOS
$7.76B
$1.23M ﹤0.01%
18,831
-174
-0.9% -$11.8K
AI icon
779
C3.ai
AI
$1.76B
$1.22M ﹤0.01%
+58,162
New +$1.65M
MCS icon
780
Marcus Corp
MCS
$848M
$1.21M ﹤0.01%
72,635
+3,977
+6% +$76.8K
BILL icon
781
BILL Holdings
BILL
$4.25B
$1.21M ﹤0.01%
26,322
-55,368
-68% -$3.72M
ASX icon
782
ASE Group
ASX
$96.2B
$1.21M ﹤0.01%
137,865
IMNM icon
783
Immunome
IMNM
$2.72B
$1.21M ﹤0.01%
179,232
-226
-0.1% -$2.17K
AKBA icon
784
Akebia Therapeutics
AKBA
$257M
$1.21M ﹤0.01%
+627,892
New +$1.28M
EPAM icon
785
EPAM Systems
EPAM
$6.48B
$1.2M ﹤0.01%
7,105
-11,954
-63% -$2.64M
TYRA icon
786
Tyra Biosciences
TYRA
$1.52B
$1.19M ﹤0.01%
+128,189
New +$1.66M
HAL icon
787
Halliburton
HAL
$29.9B
$1.18M ﹤0.01%
46,443
-27,499
-37% -$723K
AVNS
788
DELISTED
Avanos Medical
AVNS
$1.17M ﹤0.01%
81,768
+13,768
+20% +$215K
SMCI icon
789
Super Micro Computer
SMCI
$23.8B
$1.16M ﹤0.01%
+33,962
New +$1.29M
LNTH icon
790
Lantheus
LNTH
$6.57B
$1.15M ﹤0.01%
11,824
+3,564
+43% +$333K
EQT icon
791
EQT Corp
EQT
$33.4B
$1.13M ﹤0.01%
+21,206
New +$1.08M
QRVO icon
792
Qorvo
QRVO
$10.4B
$1.13M ﹤0.01%
15,624
-14,415
-48% -$1.1M
VCYT icon
793
Veracyte
VCYT
$3.2B
$1.13M ﹤0.01%
38,148
-24,955
-40% -$951K
LMT icon
794
Lockheed Martin
LMT
$123B
$1.1M ﹤0.01%
2,460
WAT icon
795
Waters Corp
WAT
$41B
$1.09M ﹤0.01%
2,963
-85
-3% -$32.9K
CSGS
796
DELISTED
CSG Systems International
CSGS
$1.09M ﹤0.01%
18,049
-37,198
-67% -$2.21M
CLVT icon
797
Clarivate
CLVT
$1.2B
$1.07M ﹤0.01%
+271,807
New +$1.29M
UAL icon
798
United Airlines
UAL
$34.5B
$1.06M ﹤0.01%
+15,344
New +$1.45M
TCBX icon
799
Third Coast Bancshares
TCBX
$748M
$1.05M ﹤0.01%
31,328
+4,469
+17% +$155K
ACGL icon
800
Arch Capital
ACGL
$33.1B
$1.04M ﹤0.01%
10,856
-27,526
-72% -$2.54M

Similar funds

Axa's Q1 2025 Portfolio in Review

As of Q1 2025, Axa held 1,158 positions worth $30.4B, down 7.5% from $32.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Axa's Q1 2025 filing shows 88 new, 431 increased, 443 reduced and 102 closed positions. Its largest new stake was JFrog: 379,366 shares worth $12.1M. The largest sale was Alphabet (Google) Class C, an estimated $91.3M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q1 2025 buy was JFrog: 379,366 shares worth $12.1M.
  • Axa added most to Salesforce in Q1 2025, an estimated $114M increase.
  • Axa's biggest Q1 2025 reduction was Alphabet (Google) Class C, cutting an estimated $91.3M.
  • Axa fully exited Service Corp International in Q1 2025, selling an estimated $24.9M.
  • Axa's ten largest holdings make up 27% of its $30.4B portfolio in Q1 2025.
  • Axa opened 88 new positions and closed 102 in Q1 2025.
  • Axa's portfolio value fell 7.5% quarter-over-quarter to $30.4B.

Based on Axa's 13F filing for Q1 2025, filed 15 May 2025.